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  In the first work, I have established a synthetic way to graft acrylic acid (AA) polymer on the 
surface of polyvinylidene fluoride (PVDF) membranes activated with the atmospheric pressure low 
temperature plasma. As a first step, the surface of PVDF membrane was treated with argon plasma. 
On the plasma-treated PVDF membrane, it was revealed that degradation reactions such as polymer 
chain scission were proceeded. On the other hand, functional groups for example hydroperoxide 
and carboxy were formed on the polymer surface. As the important efforts, I elucidated the 
activation mechanism that the initiator of graft polymerization was mainly hydroperoxide, which 
decomposed into free radicals by thermal treatment, and polymerization reactions proceeded. The 
C1s high resolution spectrum of plasma-treated PVDF membrane was decomposed into five peaks 
at BEs of 286.4, 287.4, 288.5, 289.5 and 290.9 eV. Likewise, the O1s high resolution spectrum of 
the plasma-treated PVDF membrane was curve-fitted with three peaks. On the other hand, the C1s 
high resolution spectrum of the PVDF membrane grafted with PAA (PVDF-g-PAA membrane) was 
decomposed into characteristic three peaks attributable to AA graft polymerization. The 3-D 
scaffolds of membranes in this work are intended for biotechnology application in order to maintain 
the area capable of interacting with the objective, so it is important that plasma treatment and 
subsequent AA grafting reactions minimize the interference with their porosity. As the resulrs of the 
SEM measurements, the porosity of the PVDF membrane scaffold with pore size of 0.45 µm was 
preserved after the plasma treatment. The cross sectional view of the PVDF membrane grafted with 
AA was measured by SEM-EDX. These results estimated that the PAA was densely grafted onto the 
upper of the membrane and the inside was with comparative uniform. After EDC/Sulfo-NHS 
reaction step, Bovine serum albumin (BSA) as a protein was conjugated on the PVDF-g-PAA 
membrane surface. The presence of BSA immobilized on the membranes was measured by the high 
resolution XPS. On the PVDF-g-PAA membrane, atomic nitrogen percentage decreased as low as 
0.1%. After covalently immobilizing BSA onto the PVDF-g-PAA membranes, atomic nitrogen 
percentage increased as high as 3.6%. Therefore, it was confirmed that BSA was successfully 
conjugated on the polymer-modified PVDF membranes. AFM operating in dynamic force mode 
was performed to study the surface topography of untreated PVDF, plasma-treated PVDF and 
PVDF-g-PAA membrane. The Ra of argon plasma-treated PVDF membrane surface (46.6 nm) was 
a little decreased against that of untreated PVDF membrane surface (49.8 nm). The findings implied 
that the plasma condition for introducing functional groups was mild treatment against the 
membrane surface. 
  In the second work, I have established the procedures for preparing Protein A-immobilized 
PVDF and polyether sulfone (PES) membranes to capture human IgG antibody, and characterized 
these membranes. PES has also been widely available commercially, and has excellent mechanical 
strength and is a thermally stable polymer. However, PVDF and PES have the issue of being 
intrinsically and severely hydrophobic. It was highly plausible to minimize nonspecific adsorption 
by using the hydrophilic membranes. The C1s, O1s and S2p high resolution spectrum of the 
plasma-treated PES membrane was decomposed into three, four and six peaks, respectively. As the 
results of surface properties on the membranes activated by argon plasma, several functional groups 
such as hydroperoxide, sulfide and sulfo groups were confirmed. Furthermore, the peak area ratio of 
the π-π* shake-up was comparable before and after plasma treatment. It was also suggested that 
there was low damage and disruption to the benzene ring by treating with plasma under this 
condition. Based on these data, I elucidated the activation mechanism on polymeric substrates. The 
significant findings suggest that the phenyl radical and radicals originated from hydroperoxide 
groups by thermal treatment are one of the important initiators to induce graft polymerization with 
AA on the PES membranes. The SEM images were obtained that the samples of PVDF for pore 
sizes of 0.45 µm and 5.0 µm, and the PES membrane for a pore size of 0.45 µm, respectively. The 
plasma-treated PVDF and PES membrane fibers for a pore size of 0.45 µm had grown slightly 
thicker than those for each untreated membrane surface. The porosity of the PES membrane 
scaffold was also preserved after the plasma treatment. The PVDF/PES-g-PAA membranes with a 
pore size of 0.45 µm were densely modified with PAA. The PVDF membrane with pore size of 5.0 
µm was definitely retained the macrovoid formation after the graft polymerization. These findings 
clearly indicate that it is effective to apply membranes with a pore size of 5.0 µm to maintain the 
high porosity and accessibility as affinity membranes. Adsorption isotherms of the PVDF/PES 
membranes immobilized with Protein A were constructed to investigate the capacity as affinity 
membranes. Simultaneously, nonspecific adsorption tests were performed with the 
PVDF/PES-g-PAA membranes prior to immobilization with Protein A. The adsorption isotherms 
constructed with the PVDF/PES membranes immobilized with Protein A were fitted with the 
monolayer Langmuir model. On the other hand, as the result of the nonspecific protein adsorption 
test, the equilibrium capacities of human IgG adsorbed on the membranes of the PVDF membranes 
with pore sizes of 0.45 and 5.0 µm and PES membranes with a pore size 0.45 µm were indicated to 
have relatively low levels. Finally, Protein A was successfully immobilized on the 
polymer-modified membranes. Adsorption capacities of the Protein A-immobilized membranes 
were determined and dependent on the pore size. Ligand density of the Protein A-immobilized PES 
membranes was approximately two times higher than that of the Protein A-immobilized PVDF 
membranes. The ligand density was determined using a BCA protein assay. One of the explanations 
is that the O/C atom ratio of the plasma-treated PES membrane was 0.66, which was 3.9 times 
higher than that of the plasma-treated PVDF membranes. Therefore, it was considered that the 
functional groups necessary for initiating graft polymerizations were generated more on the 
plasma-treated PES membranes relative to the PVDF membranes. In the results of the stability test, 
it was confirmed that the ligand densities were comparable, and Protein A was immobilized on the 
membrane surface rigidly. Taken together, I concluded that the atmospheric pressure low 
temperature plasma is an excellent tool for activating on the membranes to produce PVDF and 
PES-devices for biotechnological applications, and these polymers are candidates as affinity media 









288.5eV、289.5eV 及び 290.9 eV の 5 つの帰属ピークに分解された。同様に、プラズマ照射
膜の O1s 高分解能スペクトルでは、3 つの帰属ピークに分解された。一方、ポリアクリル




の結果、孔径 0.45μm の PVDF 膜構造の多孔性は、プラズマ照射後においても保持されて
いた。グラフト重合処理した PVDF 膜の断面図を SEM-EDX で測定した。その結果、ポリ
アクリル酸は照射面に高い密度でグラフトされており、膜内部は比較的均一に存在してい
ることが示された。EDC/スルホ NHS 反応後、タンパク質としての血清アルブミン（BSA）
はグラフト重合処理された PVDF 膜に固定化された。膜上に固定化された BSA は、高分解
能 XPS を用いて測定した。グラフト処理した PVDF 膜において、窒素原子比率はわずか
0.1％に減少した。グラフト処理した PVDF 膜にの BSA 固定化後、窒素原子比率は 3.6％に
も増加した。従って、BSA がポリマー修飾した PVDF 膜にうまく固定化されたことを確認
した。ダイナミックフォースモードでの原子間力顕微鏡において、PVDF 未処理膜、プラ
ズマ照射 PVDF 膜、グラフト処理 PVDF 膜の表面トポロジーの調査を行った。プラズマ照
射 PVDF 膜の平均面粗さ(46.6 nm)は、PVDF 未照射膜の平均面粗さ(49.8 nm)に対してほと
んど低下していなかった。この発見は、官能基を導入するためのプラズマ照射条件が、膜
表面に対して優しい処理であることが示唆された。 
第 2 の研究において、私はヒト IgG 抗体を捕捉するための Protein A 固定化 PVDF 及びポ
リエーテルスルホン（PES）膜の調製方法を構築し、評価した。PES も広範囲において商
業的に利用されており、優れた機械的強度を有し熱安定性の高いポリマーである。但し、
PVDF 及び PES は本質的に高い疎水性を有するという課題がある。そこで、親水化処理膜
を使うことによって、非特異的吸着を最小化することは非常に妥当な考えであった。プラ








とつであることを示した。孔径 0.45 μm と 5.0 μm の PVDF 膜と孔径 0.45 μm の PES
膜サンプルについて、それぞれ SEM 測定した。孔径 0.45 μm のプラズマ照射 PVDF 及び
PES 膜のファイバーは、それぞれの未処理膜のファイバーと比較してやや厚い形状を示し
た。孔径 0.45μm の PES 膜構造の多孔性については、プラズマ照射後においても保持され
ていた。グラフト処理した孔径 0.45 μm の PVDF 及び PES 膜は、ポリアクリル酸によっ
て高密度に修飾された。孔径 5.0μm の PVDF 膜は、グラフト重合後においてもマクロボイ
ド構造を確実に保持していた。これらの知見は、アフィニティ膜としての高い多孔性とア
クセス性を維持する上で、孔径 5.0μm の膜を採用することは効果的であることを明確に示
した。アフィニティ膜としての能力を調査するために、Protein A を固定化した PVDF 及び
PES 膜の吸着等温線を作成した。同時に、非特異的吸着試験について Protein A 固定化前の
グラフト重合処理した PVDF 及び PES 膜に対して実施した。Protein A を固定化した PVDF
及び PES 膜から得られた吸着等温線は、単分子層の Langmuir モデルにフィットしていた。
一方、非特異的吸着試験の結果、孔径 0.45 μm と 5.0 μm の PVDF 膜と孔径 0.45 μm の
PES 膜サンプルにおけるヒト IgG の平衡吸着量は相対的に低い値を示した。最終的に、
Protein A はポリマー修飾膜に首尾よく固定化された。Protein A 固定化膜の吸着能力を決定
し、その吸着能力は膜孔径に依存していた。Protein A 固定化 PES 膜のリガンド密度は、
Protein A 固定化 PVDF 膜のリガンド密度より約 2 倍高い値であった。リガンド濃度は BCA
アッセイを用いて決定した。Protein A 固定化 PES 膜のリガンド密度が高い説明として、プ





及び PES 装置を作製するため、膜活性化に対する優れた手段であり、そして PVDF 及び PES
はヒト IgG 抗体分離のためのアフィニティ媒体候補であると結論づけた。 
